ANIRUDHA DASGUPTA, MD

Plain English
This study looks at quinazoline compounds, which have shown promise in treating cancer by blocking key pathways that help cancer cells grow. Researchers found that some of these compounds effectively target cancer genes at very low concentrations, with certain combinations showing better results in killing cancer cells. This is important because it could lead to the development of new and safer cancer treatments. Who this helps: Patients with cancer seeking more effective treatment options.

Plain English
This study focused on improving a type of ink used in the production of perovskite solar cells, which significantly affects the quality and efficiency of these solar panels. Researchers discovered that by adjusting the interaction between the ink's ingredients, they could create a more stable ink that allowed for a shelf life increase and led to higher efficiency levels of 23.5% for the solar cells. This improvement also ensured that the solar cells remained effective for a long time, retaining 99% of their initial performance after 1700 hours of testing. Who this helps: This benefits manufacturers of solar panels and consumers looking for more efficient, durable solar energy solutions.

Plain English
This study looked at patients with high-grade gliomas who experienced changes in brain imaging after receiving radiation therapy. The researchers found that out of 34 patients, 18% showed complete resolution of these changes, while the majority (82%) either saw partial improvements or stable conditions over time. This matters because recognizing these differences helps doctors figure out whether patients are experiencing real disease progression or just effects from the treatment. Who this helps: This helps patients and doctors by improving the accuracy of cancer treatment evaluations.

Plain English
This study focused on improving the accuracy of predicting solar energy generation by using machine learning techniques. The researchers tested six different models and found that the Random Forest Regressor (RFR) was the most effective, achieving a high accuracy score of 0.9028, with a Mean Absolute Error of 0.6198. These findings are important because better predictions of solar energy can help reduce costs and improve the integration of solar power into the energy grid. Who this helps: This helps solar energy providers and energy grid managers.

Plain English
This study focused on how different chloride additives affect the quality of perovskite films used in solar cells. Researchers found that using a combination of two chloride additives improved the performance of solar cells, achieving efficiencies of 26.4% for smaller devices and 24.5% for larger ones. This matters because these solar cells also showed strong stability, maintaining 88% of their performance after 1200 hours of operation at high temperatures, which is important for practical use. Who this helps: This benefits solar energy developers and manufacturers looking to create more efficient and durable solar panels.

Plain English
This study looked at how brain tumors linked to genetic disorders called phakomatoses affect patients treated at a specialized center in India. It analyzed 121 patients between 2000 and 2022 and found that those with Neurofibromatosis type 1 (NF1) had a 3-year survival rate of 87.7%, while patients with Neurofibromatosis type 2 (NF2), Von Hippel-Lindau (VHL), and Tuberous Sclerosis Complex (TSC) had even higher survival rates at 100%. These findings highlight the importance of tailored treatment approaches for these challenging tumors, which could lead to improved patient outcomes. Who this helps: This helps patients with CNS tumors linked to phakomatoses and their healthcare providers.

Plain English
This study looked at whether memantine, a medication, could help preserve memory and thinking skills in young patients (ages 5 to 39) who received craniospinal irradiation (CSI) to treat brain tumors. The goal was to see if more patients could avoid cognitive decline after two years, aiming for 75% in the memantine group compared to 50% in the standard care group. If successful, memantine could become a standard treatment alongside CSI, helping protect cognitive function for these patients. Who this helps: This helps young patients undergoing treatment for brain tumors.

Plain English
This study compares two types of radiation therapy—proton beam therapy (PBT) and traditional photon therapy—for adults aged 18-70 with primary brain tumors, all of whom are expected to survive more than five years. The goal is to see which treatment helps patients maintain their mental and physical functions over five years, with an aim for PBT to improve functional survival from 40% to 65%. This is important because better functional outcomes can lead to improved quality of life for patients with brain tumors. Who this helps: This helps patients with brain tumors and their doctors.

Plain English
This study looked at how certain genetic changes in brain tumors, specifically high-grade gliomas, affect patient outcomes in India. Among 395 patients treated in the same way, 15.4% had mutations in the IDH gene and 36.7% had methylation of the MGMT gene, with an average survival time of 19 months. The research found that age over 50, having less than 6 cycles of treatment, and not having the IDH mutation were all linked to worse survival rates, emphasizing the importance of these genetic markers in guiding treatment decisions. Who this helps: This research benefits patients and doctors by improving understanding of how to tailor treatment strategies for brain tumor patients.

Plain English
Researchers found a structure called the fusome in mammals, which is similar to ones seen in other species. This discovery shows that certain biological processes for developing reproductive cells have been preserved throughout evolution. Understanding the fusome can provide insights into how reproductive cells function, which is important for fertility studies. Who this helps: This helps researchers and doctors working in reproductive health.

Plain English
This study looked at how certain clinical and genetic factors, particularly a variation in the MGMT gene, can predict serious side effects from the cancer drug temozolomide (TMZ) in adults with diffuse glioma. They found that women were 5.4 times more likely to experience severe side effects, those with a smaller body surface area had a 3.8 times higher risk, and people with a specific genetic variant had a 5.0 times greater chance of severe reactions. These findings can help caregivers identify patients who may be at higher risk for harmful effects from this treatment. Who this helps: Patients with diffuse glioma and their healthcare providers.

Plain English
This study explored how machine learning can help classify types of kidney tumors using detailed imaging and clinical data from 448 patients. The researchers found that their best algorithms could accurately identify aggressive tumors 90% of the time and distinguish between benign and malignant tumors 76% of the time, with tumor size being an important factor in improving accuracy. These findings show that machine learning can improve the way doctors assess the risks of kidney tumors, leading to more tailored treatment options for patients. Who this helps: This helps patients with kidney tumors and their doctors by improving tumor risk assessments.

Plain English
This research focused on chalcones, a type of natural compound known for their potential in fighting cancer. The review highlighted how specific changes to the chemical structure of chalcones can increase their effectiveness against cancer cells. For instance, certain modifications to the chalcone structure showed promising cytotoxic effects in various cancer types, pointing to their potential as future cancer treatments. Who this helps: This benefits cancer patients and researchers looking for new treatment options.

Plain English
This study focused on creating new chemical compounds called hetero[3.1.1]propellanes, which include different atoms like oxygen, nitrogen, and sulfur in their structure. The researchers developed a unique method to produce these compounds efficiently and found that they can easily transform into valuable bicyclic structures useful for making drugs. These new compounds are important because they can lead to better drugs with improved properties compared to existing options. Who this helps: This benefits drug developers and researchers in the pharmaceutical industry.

Plain English
This research studied how a component from mycobacteria, called sulfoglycolipid-1 (SL-1), affects the structure and movement of our cells during infection. The team found that SL-1 changes how specific lipids and actin (a vital protein for cell shape and movement) interact, ultimately leading to increased bacterial entry into cells. This is important because understanding these changes can help develop strategies to fight tuberculosis and improve treatments. Who this helps: This helps patients with tuberculosis and healthcare providers looking for new treatment options.

Plain English
This study looked at a serious condition called thyroid storm that resembles sepsis, where symptoms include fever, vomiting, agitation, and rapid heart rate. A 31-year-old man with no previous thyroid problems experienced severe liver damage and low potassium levels alongside elevated thyroid hormones. Instead of the usual treatment, which was risky due to his liver condition, doctors used alternative medications like lithium to stabilize him, allowing them to start traditional treatment later. Who this helps: This helps patients with thyroid storm, especially those with liver issues who need urgent care.

Plain English
This study focused on the importance of tracking errors in laboratory tests, which can significantly harm patient care, affecting 26-30% of reported errors. The researchers developed a database called C-LED that collects and shares detailed information on laboratory errors and their impacts, using advanced techniques including artificial intelligence to streamline data collection from various sources. This effort is crucial because it aims to improve the accuracy of laboratory results, ultimately increasing patient safety worldwide. Who this helps: This helps patients by ensuring more accurate lab tests, doctors in making better clinical decisions, and laboratory professionals in understanding and preventing errors.

Plain English
This study examined how the organization of the Golgi apparatus in cells is affected by their adhesion to their surroundings. Researchers found that when cells lose their attachment, the Golgi becomes disorganized and the microtubules, which help maintain cell structure, become less acetylated. Specifically, re-attaching cells restored acetylation levels, highlighting that the interaction between the Arf1 protein and the motor proteins KIF5B and dynein is crucial for maintaining Golgi function and organization. Who this helps: This research benefits scientists studying cell behavior and could inform doctors about issues related to cell adhesion in cancers or tissue repair.

Plain English
This study looked at the effectiveness of two methods for measuring tacrolimus, a drug used to prevent organ rejection in transplant patients. It found that out of nearly 52,000 tests, only 1.5% required a second, more precise test (LC-MS/MS), but 3.4% of those showed significant differences from the first test, highlighting the need for confirmatory testing in certain cases. This matters because accurate monitoring of tacrolimus levels is essential for patient safety and treatment success. Who this helps: This helps patients receiving tacrolimus, particularly transplant recipients.

Plain English
This study looked at a man with a serious blood condition who had severe allergic reactions after receiving blood transfusions, specifically from group B donors. It was found that he had a slightly elevated reaction to a specific carbohydrate linked to alpha-gal syndrome, which is an allergy that can develop after tick bites and is typically triggered by eating mammal meat. After avoiding group B platelets, he no longer experienced allergic reactions, which suggests that patients with this condition should not receive blood products from group B. Who this helps: This research is important for patients with alpha-gal syndrome and doctors who manage blood transfusions for them.

Plain English
This study looked at young people with type 2 diabetes to see if a liver enzyme called gamma glutamyl transferase (GGT) could help identify severe liver damage. Researchers found that 41% of the patients had serious liver fibrosis, and for every 10-unit increase in GGT, the chances of having severe fibrosis increased by 20%. This is important because it could offer a simpler way to screen for liver issues in young diabetes patients without needing more invasive tests. Who this helps: This helps doctors and healthcare providers working with young patients who have type 2 diabetes.

Plain English
This study looked at patients with critically low platelet counts caused by giant platelets, which automated testing sometimes cannot measure accurately. Researchers found that in over 150,000 blood tests, only five patients had a high number of giant platelets, and in three of those cases, no platelet transfusion was needed because their bleeding risk was assessed as normal. This matters because it shows that a specific testing method (thromboelastography) can effectively evaluate bleeding risk in patients with problematic platelet counts, which helps guide better treatment decisions. Who this helps: This helps critically ill patients with low platelet counts and their doctors.

Plain English
This research studied how the SARS-CoV-2 virus affects mitochondria in various cells, particularly in the lungs, leading to problems commonly seen in COVID-19 pneumonia. They found that the virus quickly disrupts mitochondrial functions, which are crucial for energy production, and leads to cell damage and death. Specifically, they noted significant changes in genes related to mitochondrial energy production, and this damage may play a role in long COVID symptoms. Who this helps: This research benefits patients with COVID-19 and may help doctors find better treatments.

Plain English
This study looked at how problems with finding and keeping stable, quality housing affect people struggling with opioid use disorders. Researchers interviewed 85 community leaders in New York State and found that issues like high housing costs, poor living conditions, and neighborhood challenges are linked to higher rates of substance use and difficulty in staying in treatment. Addressing these housing problems is important because stable housing can improve health outcomes and help people stay in recovery. Who this helps: This helps patients with opioid use disorders and the community organizations supporting them.

Plain English
This study looked at how the presence of a specific antibody called anti-Ro60 is linked to kidney damage in patients with lupus nephritis, a serious kidney condition related to lupus. Researchers found that out of 41 patients, those who tested positive for anti-Ro60 had a higher likelihood of experiencing more severe kidney damage, with a significant strength in this association when excluding one extreme case. Notably, Black patients also showed a stronger correlation with severe kidney damage, highlighting ongoing racial disparities in health outcomes. Who this helps: Patients with lupus nephritis and their doctors can benefit from understanding these factors to better assess risk and treatment options.

Plain English
This study looked at how surviving sepsis affects brain function and memory in mice. Researchers found that mice who experienced surgical sepsis showed significant memory problems, with a nearly 70% decrease in their ability to recognize previously encountered objects two months after the event. These brain changes are linked to a loss of specific brain cells and altered immune responses, which explains why so many sepsis survivors struggle with cognitive issues even after recovery. Who this helps: This research benefits doctors and researchers working to improve care for sepsis patients.

Plain English
This study looked at a protein called dynamin 2 (DNM2) and its role in the process of cell division in the context of pulmonary arterial hypertension (PAH), a condition that affects blood vessels in the lungs. The researchers found that DNM2 levels were higher in cells from patients with PAH, and when they interfered with DNM2, it reduced cell growth and increased cell death, suggesting DNM2 is essential for the disease's progression. By targeting DNM2, they also saw improvements in lung conditions in rats with pulmonary hypertension, indicating it could be a promising target for new treatments. Who this helps: This helps patients with pulmonary arterial hypertension.

Plain English
This research looked at how changes in genetic activity, without altering the DNA sequence, play a role in cancer development and treatment. The study found that specific markers related to these changes have been identified across various types of cancers, aiding in better diagnosis and treatment. Considering that new drugs targeting these changes can improve how we treat difficult-to-treat cancers, this research opens up new possibilities for customized treatment approaches that can lead to better outcomes for patients. Who this helps: This helps patients with cancer by offering potential new treatment options and personalized therapies.

Plain English
This study looked at a 75-year-old man who had a rare blood antibody called anti-AnWj, which is found in fewer than 1% of people. Despite having serious health conditions and requiring a blood transfusion, doctors were unable to find compatible blood due to this rare antibody. They proceeded with the transfusion without matching for the anti-AnWj antigen, and fortunately, he had no negative reactions, highlighting the challenges of treating patients with rare blood antibodies in critical situations. Who this helps: This helps doctors treating patients with rare blood antibodies.

Plain English
This study looked at how long it takes for women diagnosed with cervical cancer to start their treatment around the world. On average, it takes about 71 days from diagnosis to treatment, which is much longer than the recommended 30 to 60 days. The research found that in high-income countries, patients waited about 40 days, while those in upper-middle-income countries waited nearly 95 days, revealing significant delays that can hurt survival chances. Who this helps: This research benefits patients, healthcare providers, and policymakers focused on improving cervical cancer care.

Plain English
This study explored how to improve the process of creating mRNA, which is crucial for mRNA vaccines. Researchers developed a detailed model that breaks down the transcription process into different stages and used data to predict how efficient and high-quality the mRNA would be. They found that using a mix of traditional modeling and machine learning techniques helps design better manufacturing processes, potentially boosting yields and product quality. Who this helps: This benefits vaccine manufacturers and researchers working on mRNA therapies.

Plain English
This study looked at how to improve the tracking and analysis of infectious diseases, highlighting the benefits of a method called "federated approaches." These methods allow researchers to analyze data from different sources without moving the sensitive data itself, helping overcome challenges in sharing important outbreak information. By using federated methods, public health efforts can respond more effectively to disease outbreaks, ultimately benefiting global health initiatives. Who this helps: This helps patients, healthcare providers, and public health organizations.

Plain English
This study focused on improving brain MRI images taken from different machines so that they look more similar and can be compared more accurately. Researchers developed a new technique using advanced computer algorithms and found that their method, called FP-cGAN, performed better than traditional methods in making inconsistent images consistent while keeping important brain features intact. The new approach not only improved the quality of the images but also provided helpful information about the uncertainty of the results. Who this helps: This benefits doctors and researchers working on neurological disorders by providing clearer images for diagnosis and study.

Plain English
This study looked at how smoking affects feelings of loneliness among people living in extended-stay hotels in Atlanta, Georgia, many of whom are low-income. Researchers found that while smoking alone doesn’t predict loneliness levels, gender plays a role: female smokers reported feeling lonely less often than male smokers. This is important because understanding these factors can help improve support and community connections for residents facing housing and health challenges. Who this helps: This helps patients living in extended-stay hotels and the professionals working to support them.

Plain English
This study looked at a type of aggressive brain tumor called H3K27M-altered diffuse midline glioma (DMG) in 225 patients in a low- to middle-income country. After treatment, the findings showed that only about 31% of patients survived for a year without their disease worsening, and half lived for about a year after diagnosis. The results highlight that this type of tumor is difficult to treat, and there is a pressing need for better treatments. Who this helps: This research benefits doctors and researchers working to improve treatment options for patients with this aggressive brain tumor.

Plain English
This study examined how changes in tumor size during early chemotherapy could predict how well breast cancer patients respond to treatment. Researchers looked at 106 patients and found that those who completely responded to the therapy had significant reductions in tumor size within the first few weeks, while those who showed only partial or weak responses had smaller changes. This information is important because it could help doctors tailor treatments more effectively in the future and reduce unnecessary side effects and costs. Who this helps: This helps breast cancer patients and their doctors make better treatment decisions.

Plain English
This study looked at how the way kidney biopsy samples are preserved affects the detection of certain proteins important for diagnosing specific blood diseases. Researchers found that kidney samples preserved in Michel transport medium had significantly weaker signals for these proteins compared to those preserved in formalin, with signals completely absent in some cases (p < 0.001). This is important because accurate detection is vital for proper diagnosis and treatment decisions. Who this helps: This helps doctors and patients by ensuring more accurate diagnoses in kidney disease.

Plain English
This study focused on a crucial enzyme in the tuberculosis bacteria, Mycobacterium tuberculosis (Mtb), called GAPDH. Researchers found that blocking this enzyme with certain drugs and using vitamin C significantly increased the bacteria's destruction, improving the chance of treating tuberculosis effectively. In animal tests, vitamin C enhanced the effects of other drugs, leading to higher levels of reactive oxygen species that attack the bacteria. Who this helps: This benefits patients with tuberculosis by potentially providing new treatment options.

Plain English
Researchers studied Ujvira®, a more affordable version of a standard treatment for HER2-positive metastatic breast cancer, to see how well it works and its safety in real-world settings. They found that the median time patients lived without cancer progression was about 6.9 months, with a response rate of 35.3%, showing it worked similarly to the original treatment. This matters because it provides a viable option for patients in low-income areas who cannot afford the pricier treatments. Who this helps: Patients with HER2-positive metastatic breast cancer, especially in low- and middle-income countries.

Plain English
This study examined how participatory mapping (PM) can improve health research by involving communities in understanding health issues related to geography. Researchers reviewed 39 studies and found that even though the use of PM has increased since the 2010s, there is still confusion about what it means to participate effectively. They created a new framework to clarify how to use PM in health research, which might help communities gain better health outcomes by making research more inclusive and transparent. Who this helps: This benefits communities, health researchers, and policymakers.

Plain English
This study focused on how changes in a key enzyme, Topoisomerase II, can create barriers to reproduction between different species of fruit flies (Drosophila). The researchers found that specific adaptations in this enzyme lead to problems when DNA is copied during embryo development, which can cause hybrid embryos to fail. This matters because it highlights how even essential genes can play a role in preventing closely related species from successfully mating. Who this helps: This helps researchers studying species evolution and reproductive barriers.

Plain English
Scientists analyzed the gravitational wave signal GW250114 — the strongest ever detected — to test whether the black hole produced by the merger behaves exactly as Einstein's general relativity predicts. The analysis confirmed at least two distinct oscillation modes in the signal and measured their frequencies to within a few percent of theoretical predictions, providing the most stringent single-event test of general relativity to date. These results validate both the theory and the Kerr description of black holes with unprecedented precision.

Plain English
This study looked at how well two different antibodies (Dako and Kent) detect a specific type of kidney cell staining in patients with a condition called minimal change disease, which often does not respond to steroid treatments. The researchers found that both antibodies were effective at recognizing the "powdery" staining in these patients. This matters because identifying this staining can help doctors make more accurate diagnoses and better treat patients who struggle with this kidney condition. Who this helps: Patients with minimal change disease and their doctors.

Plain English
This research explored how doctors in India view empagliflozin, a medication for type 2 diabetes, particularly for patients with heart or kidney issues. Most clinicians (95%) believe that empagliflozin should be a main treatment for diabetes in patients with heart disease, and 93% support its use for preventing heart failure and slowing kidney disease. This is important because using empagliflozin early can significantly improve health outcomes for high-risk diabetes patients. Who this helps: Patients with type 2 diabetes, especially those with heart and kidney conditions.

Plain English
This paper discusses a large workshop that took place in 2025, gathering over 1,200 professionals from the pharmaceutical industry and regulatory agencies to tackle important issues in bioanalysis—the study of biological samples. Key recommendations from the workshop include better practices for using advanced technology in testing methods and improving compliance with regulations, focusing on different areas like gene and cell therapies. These findings are important because they aim to enhance the quality and accuracy of tests that ensure new medical treatments are safe and effective. Who this helps: Patients and healthcare providers involved in new therapies and drug development.